Synergy names Bausch entities as winning bidder for company assets

By Caroline Salls

Pittsburgh, Feb. 27 – Synergy Pharmaceuticals Inc. has selected stalking horse bidder Bausch Health Cos. Inc. and Bausch Health Ireland Ltd. as the winning bidder for its assets, according to a notice filed Tuesday with the U.S. Bankruptcy Court for the Southern District of New York.

As previously reported, Bausch has agreed to pay $200 million for the Synergy assets.

The sale hearing is scheduled for March 1.

Synergy is a New York-based biopharmaceutical company focused on the development and commercialization of novel gastrointestinal therapies. The company filed bankruptcy on Dec. 12 under Chapter 11 case number 18-14010.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.